RESUMO
Salmonella enterica serotype Typhi (S Typhi) associated urinary tract infections are exceedingly rare, accounting for less than 1% of cases. Such infections have known to occur in immune-compromised or individuals with urogenital structural abnormalities. With the emergence of extensively drug resistant S Typhi strains in Pakistan, the management of its various unique presentations poses therapeutic challenges. We report the first documented case of a 74 years old male patient presenting with relapsed urinary tract infection secondary to extensively drug resistant S Typhi.
Assuntos
Antibacterianos , Farmacorresistência Bacteriana Múltipla , Recidiva , Salmonella typhi , Febre Tifoide , Infecções Urinárias , Humanos , Masculino , Salmonella typhi/efeitos dos fármacos , Salmonella typhi/isolamento & purificação , Infecções Urinárias/microbiologia , Infecções Urinárias/tratamento farmacológico , Febre Tifoide/microbiologia , Febre Tifoide/tratamento farmacológico , Idoso , Antibacterianos/uso terapêutico , Antibacterianos/farmacologia , Paquistão , Testes de Sensibilidade MicrobianaRESUMO
Dengue fever (DF) primarily presents with fever, headache, malaise, bleeding manifestations and haemoconcentration. World Health Organization (WHO) classifies DF according to levels of severity: (a) without warning signs; (b) with warning signs, such as abdominal pain, persistent vomiting, fluid accumulation, mucosal bleeding, lethargy, liver enlargement, increasing haematocrit and thrombocytopenia; and (c) severe dengue with severe plasma leakage, severe bleeding or organ failure. Atypical clinical presentations of DF are defined as expanded dengue syndrome: this includes renal, cardiac, hepatic or cerebral damage. We report such a severe case where a young man developed acute kidney injury, acute fulminant liver failure and acute pancreatitis secondary to DF, but recovered.